Questioning the role of selected somatic PIK3C2B mutations in squamous non-small cell lung cancer oncogenesis
Marcus Kind(University Children’s Hospital Bern), Roch‐Philippe Charles(University of Bern)
Cited by 8
Related Papers
Combined MEK and Pi3′-kinase inhibition reveals synergy in targeting thyroid cancer <i>in vitro</i> and <i>in vivo</i>
|Oncotarget|2017|25
Questioning the role of selected somatic <i>PIK3C2B</i> mutations in squamous non-small cell lung cancer oncogenesis
|bioRxiv (Cold Spring Harbor Laboratory)|2017|0